This is the first known report of a child with severe CMA—defined by milk-specific IgE >100 kUA/L and anaphylaxis to 1.1 mL—achieving unrestricted intake through long-term, slow, ultra-low-dose OIT. The gene discussed is IGHE; the disease is anaphylaxis.